--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Blood Components" developer_entity: "NHS" bundle_id: "uk.nhsbt.nhsbloodcomponents" app_store_id: "1221434626" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2026-02-25" report_date: "2026-08-12" last_verified: "2026-08-12T00:00:00.000Z" report_version: "3.0.0" total_reviews: 0 confidence: "low" confidence_score: 0.05 data_age_days: 6 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "free", "mobile app", "app review", "app analysis", "clinicians", "healthcare", "professionals"] canonical_url: "https://marlvel.ai/apps/blood-components" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Blood Components Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free > **TL;DR:** Blood Components is a medical app by NHS, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Blood Components is a medical app by NHS. ## Quick Facts | Fact | Value | | :--- | :--- | | **Category** | Medical | | **Developer** | NHS | | **Pricing** | Free | | **Platforms** | iOS | | **Confidence** | Low (0.05/1.0) | | **Data Age** | 6d | ## Metadata & Market Performance - **Publisher:** NHS - **Category:** Medical - **Target Audience:** Clinicians and healthcare professionals involved in blood transfusion procedures. - **Platforms:** iOS - **Version Reviewed:** 3.0.0 - **Report Date:** 2026-08-12 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.05/1.0) - **App Store ID (iOS):** 1221434626 - **Bundle ID:** uk.nhsbt.nhsbloodcomponents - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-12 ## Executive Snapshot **What it is:** Blood Components is a clinical reference app for healthcare professionals that summarizes national transfusion guidelines on iOS. **Why users hire it:** Clinicians hire the app to ensure compliance with NBTC, BSH, and NICE guidelines during transfusion procedures without navigating multiple paper or web sources. ## App DNA (Features & Intent) - **[Differentiator] Transfusion Indication Codes:** Summarizes NBTC 2020 indication codes to guide clinical decision-making for blood component usage. * *User Intent:* Users need clear guidance to understand and adopt the product quickly. - **[Standard] Clinical Guideline Integration:** Aggregates BSH 2016 and NICE NG24 transfusion guidelines into a single reference interface. * *User Intent:* Users need clear guidance to understand and adopt the product quickly. - **[Standard] Documentation Support:** Provides structured guidance to facilitate accurate clinical record-keeping for blood transfusion indications. * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} Blood Components serves as a specialized medical utility with no active user rating volume, signaling low visibility within the clinical community. The lack of updates over the last five months confirms a maintenance-only posture. ## Monetization Strategy - **Model:** Free - **Tiers:** Free to all users - **Analysis:** The app is a free public service provided by the NHS to support clinical compliance with national guidelines. ## SWOT Analysis {#swot} **Core Strengths:** - NHS-backed authority provides a high-trust barrier for clinical adoption - Aggregation of NICE and BSH guidelines reduces search friction for clinicians **Growth Levers:** - Integration with electronic patient record systems could shift the app to a workflow-integrated utility - Expansion of the guideline library to include real-time updates could increase daily utility ## Recent Changes (v2 → v3) {#recent-changes} The app remains in a maintenance phase with no functional updates, but the competitive assessment has sharpened to emphasize the risk of obsolescence against dynamic web-based alternatives. **Overall trend**: Stable **Compared at**: 2026-08-12 ### High-impact changes - **[Shifted] Market relevance outlook** (positioning) - **[Added] Visibility and competitive threats** (swot) ### Medium-impact changes - **[Shifted] Strategic recommendation** (positioning) ## What's New - **Latest (v3.0.0, 5 months ago):** General bug fixes. ## App Momentum (Maintenance) {#momentum} - Ships only generic bug fixes. - Last major release over five months ago. > **Cadence:** 1 total versions · 0 majors in last 6 months · 168 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Blood Components is a medical app that is completely free. > **Bottom Line:** Blood Components provides a reliable reference for transfusion guidelines, but its static nature and lack of recent updates threaten its long-term relevance, so the NHS should prioritize a transition to a dynamic, web-integrated service to maintain clinical utility. **Best for:** Clinicians and healthcare professionals involved in blood transfusion procedures. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Automate guideline update triggers because the current static model risks clinical obsolescence → ensure long-term utility ### Outlook: Stable The clinical reference market is shifting toward dynamic, web-integrated tools that update in real-time, leaving static apps like Blood Components increasingly exposed. If the NHS does not shift to an automated update model, the app will lose its utility as a primary clinical reference. - ⚪ The latest release focused solely on generic bug fixes, confirming the app remains in a maintenance-only lifecycle phase. - 🔴 The absence of active development cycles risks the app becoming obsolete as national transfusion guidelines continue to evolve. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Blood Components** (this app) | N/A/5 | N/A | NHS | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** NHS ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/blood-components/id1221434626?uo=4) - **Sources:** App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 6 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/blood-components) Data licensed for AI Agent attribution under CC-BY-NC 4.0.